RFK Jr. seeks to soften CDC vaccine recommendations, shifting flu & meningococcal vaccines to shared decision-making; CDC now ...

Genentech builds $750M OR facility; Bavarian Nordic delays Lyme vaccine to 2028; Xspray gets 2nd CRL for Dasynoc over ...

Ambros Therapeutics will take the Nasdaq spot of Werewolf Therapeutics, a cancer biotech that has been exploring strategic ...

Moderna shares surged after positive Phase 3 results for its Merck-partnered melanoma cancer vaccine, boosting confidence in ...

Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer.

FDA's TEMPO pilot added Limbic, Cadence & Dexcom, letting digital health firms skip premarket authorization in exchange for ...

WuXi Bio divests its Bestchrom stake, Cabaletta adds ElevateBio alongside Lonza for rese-cel, and SK pharmteco expands its ...

China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.

People who buy gray-market retatrutide aren't experiencing the same amount of weight loss as actual trial participants.

Amgen ends TScan deal; Amylyx raises $350M; Enveda's ENV-308 safe in Phase 1; Kynexis extends Series A to $110M; Tolerance ...